Corvus Pharmaceuticals, Inc. (CRVS)
Nasdaq: CRVS · CIK 0001626971 · United States
Every official Corvus Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open CRVS filings
Corvus Pharmaceuticals, Inc. documents
- Corvus Pharmaceuticals, Inc. 10-K 2026CRVS 10-K 2026: annual report for fiscal 2026
- Corvus Pharmaceuticals, Inc. 10-K 2025CRVS 10-K 2025: annual report for fiscal 2025
- Corvus Pharmaceuticals, Inc. 10-K 2024CRVS 10-K 2024: annual report for fiscal 2024
- Corvus Pharmaceuticals, Inc. 10-K 2023CRVS 10-K 2023: annual report for fiscal 2023
- Corvus Pharmaceuticals, Inc. 10-K 2022CRVS 10-K 2022: annual report for fiscal 2022
- Corvus Pharmaceuticals, Inc. 10-Q 2026CRVS 10-Q 2026: quarterly report for fiscal 2026
- Corvus Pharmaceuticals, Inc. 10-Q 2025CRVS 10-Q 2025: quarterly report for fiscal 2025
- Corvus Pharmaceuticals, Inc. 10-Q 2024CRVS 10-Q 2024: quarterly report for fiscal 2024
- Corvus Pharmaceuticals, Inc. 10-Q 2023CRVS 10-Q 2023: quarterly report for fiscal 2023
- Corvus Pharmaceuticals, Inc. 10-Q 2022CRVS 10-Q 2022: quarterly report for fiscal 2022
- Corvus Pharmaceuticals, Inc. 8-K 2026CRVS 8-K 2026: current report for fiscal 2026
- Corvus Pharmaceuticals, Inc. 8-K 2025CRVS 8-K 2025: current report for fiscal 2025
- Corvus Pharmaceuticals, Inc. 8-K 2024CRVS 8-K 2024: current report for fiscal 2024
- Corvus Pharmaceuticals, Inc. 8-K 2023CRVS 8-K 2023: current report for fiscal 2023
- Corvus Pharmaceuticals, Inc. 8-K 2022CRVS 8-K 2022: current report for fiscal 2022
- Corvus Pharmaceuticals, Inc. DEF 14A 2026CRVS DEF 14A 2026: proxy statement for fiscal 2026
- Corvus Pharmaceuticals, Inc. DEF 14A 2025CRVS DEF 14A 2025: proxy statement for fiscal 2025
- Corvus Pharmaceuticals, Inc. DEF 14A 2024CRVS DEF 14A 2024: proxy statement for fiscal 2024
- Corvus Pharmaceuticals, Inc. DEF 14A 2023CRVS DEF 14A 2023: proxy statement for fiscal 2023
- Corvus Pharmaceuticals, Inc. DEF 14A 2022CRVS DEF 14A 2022: proxy statement for fiscal 2022
- Corvus Pharmaceuticals, Inc. Form 4 2026CRVS Form 4 2026: insider trading filing for fiscal 2026
- Corvus Pharmaceuticals, Inc. Form 4 2025CRVS Form 4 2025: insider trading filing for fiscal 2025
- Corvus Pharmaceuticals, Inc. Form 4 2024CRVS Form 4 2024: insider trading filing for fiscal 2024
- Corvus Pharmaceuticals, Inc. Form 4 2023CRVS Form 4 2023: insider trading filing for fiscal 2023
- Corvus Pharmaceuticals, Inc. Form 4 2022CRVS Form 4 2022: insider trading filing for fiscal 2022
- Corvus Pharmaceuticals, Inc. S-1 2026CRVS S-1 2026: registration statement for fiscal 2026
- Corvus Pharmaceuticals, Inc. S-1 2025CRVS S-1 2025: registration statement for fiscal 2025
- Corvus Pharmaceuticals, Inc. S-1 2024CRVS S-1 2024: registration statement for fiscal 2024
- Corvus Pharmaceuticals, Inc. S-1 2023CRVS S-1 2023: registration statement for fiscal 2023
- Corvus Pharmaceuticals, Inc. S-1 2022CRVS S-1 2022: registration statement for fiscal 2022
- Corvus Pharmaceuticals, Inc. 13F 2026CRVS 13F 2026: institutional holdings for fiscal 2026
- Corvus Pharmaceuticals, Inc. 13F 2025CRVS 13F 2025: institutional holdings for fiscal 2025
- Corvus Pharmaceuticals, Inc. 13F 2024CRVS 13F 2024: institutional holdings for fiscal 2024
- Corvus Pharmaceuticals, Inc. 13F 2023CRVS 13F 2023: institutional holdings for fiscal 2023
- Corvus Pharmaceuticals, Inc. 13F 2022CRVS 13F 2022: institutional holdings for fiscal 2022
More companies